NOTE:     The following Minutes are provided for informational purposes only.

If you would like to obtain an official copy of these Minutes, please contact the

State Board of Pharmacy at 614/466-4143 for instructions and fee.

 

 

 

Minutes Of The Meeting

Ohio State Board of Pharmacy

Columbus, Ohio

February 21, 2000

 

MONDAY, FEBRUARY 21, 2000

 

  8:13 a.m.     ROLL CALL

 

The State Board of Pharmacy convened in Room 1948, Vern Riffe Center for Government and the Arts, 77 South High Street, Columbus, Ohio with the following members present:

 

Robert B. Cavendish, R.Ph. (President); Diane C. Adelman, R.Ph. (Vice-President); Ann D. Abele, R.Ph.; Suzanne R. Eastman, R.Ph.; Lawrence J. Kost, R.Ph.; Amonte B. Littlejohn, R.Ph.; Suzanne L. Neuber, R.Ph.; and Nicholas R. Repke, Public Member.

 

Also present were William T. Winsley, Executive Director; Timothy Benedict, Assistant Executive Director; and David Rowland, Legal Affairs Administrator.

  8:14 a.m.

Ms. Abele moved that the Board go into Executive Session for the purpose of the investigation of complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Revised Code.  The motion was seconded by Mr. Repke and a roll call vote was conducted by President Cavendish as follows: Abele-Yes, Adelman-Yes, Eastman-Yes, Kost-Yes, Littlejohn-Yes, Neuber-Yes, and Repke-Yes.

11:18 a.m.

The Executive Session ended and the Board meeting resumed in Public Session.

11:19 a.m.

RES. 2000-122     Ms. Eastman moved that the Board accept the settlement offers as agreed by the Board and the respondents in the matters of John Lafferty, R.Ph., Cleveland; Imogene Carol Maynard, R.Ph., Cleveland; and Suellen Ogden, R.Ph., Elyria.  The motion was seconded by Mr. Littlejohn and approved by the Board (Aye-7/Nay-0).

11:25 a.m.

The meeting was recessed to allow the attorneys for the Board and the respondents to summarize the pertinent points of the agreement in writing pending a formal settlement agreement being drawn up and signed by all parties.

  1:00 p.m.

The Board meeting continued in Room 1948 with all members except Mr. Giacalone present.  Mr. Repke moved that the Board go into Executive Session for the purpose of the investigation of complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Revised Code.  The motion was seconded by Mr. Littlejohn and a roll call vote was conducted by President Cavendish as follows: Abele-Yes, Adelman-Yes, Eastman-Yes, Kost-Yes, Littlejohn-Yes, Neuber-Yes, and Repke-Yes.

  1:20 p.m.

RES. 2000-123     The Executive Session ended and the Board meeting resumed in Public Session.  Ms. Abele then moved that, pursuant to Section 3719.121 of the Revised Code, the Board summarily suspend the license to practice pharmacy belonging to Elizabeth Hartranft, R.Ph. (03-3-08439) due to the fact that a continuation of her professional practice presents a danger of immediate and serious harm to others.  The motion was seconded by Ms. Eastman and approved by the Board (Aye-7/Nay-0).

  1:30 p.m.

Mr. Repke moved that the Board receive Per Diem as follows:

 

PER DIEM           2/21          Total

Abele                1             1

Adelman              1             1

Cavendish            1             1

Eastman              1             1

Giacalone            -             -

Littlejohn           1             1

Kost                 1             1

Neuber               1             1

Repke                1             1

 

The motion was seconded by Mrs. Adelman and approved by the Board (Aye-7/Nay-0).

  1:32 p.m.

Mr. Repke moved that the meeting be adjourned.  The motion was seconded by Mrs. Adelman and approved (Aye-7/Nay-0).

 

 

  /s/                  Robert B. Cavendish                           /d/    March 7, 2000      

                  Robert B. Cavendish, President                                       Date

 

                              /s/                      W  T  Winsley                          

                                    William T. Winsley, Executive Director